top of page
The latest from NuvOx
Search
NuvOx Appoints Dr. Robert King to SAB
Tucson, AZ, May 9th, 2022 – https://www.pr.com/press-release/861001 NuvOx Pharma, a clinical stage biotechnology company developing a...
May 9, 2022
NuvOx Technology Featured in Prominent Peer Review Journal
Tucson, AZ, April 19, 2022 -- https://www.pr.com/press-release/859633 NuvOx Pharma’s technology, which is developed as a first-in-class...
May 9, 2022
NuvOx Finalizes Facility Certification, Poising for Phase IIb Trials
Tucson, AZ, April 17, 2022 -- https://www.pr.com/press-release/859467 NuvOx Pharma, a clinical stage biotechnology company developing a...
May 9, 2022
NuvOx Receives Notice from the Breakthrough DOD Award for its Immuno-Oncology Program
On February 11th, 2022,-- https://www.pr.com/press-release/859467 NuvOx Pharma received notice from the Department of Defense (DOD)...
Mar 4, 2022
NuvOx to Participate in the BIO CEO Investor Conference
Tucson, AZ, February 10, 2022 – NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat...
Feb 9, 2022
bottom of page